4BB vs. AVCT, FUM, FARN, SCLP, HVO, POLB, REDX, BVXP, ETX, and TRX
Should you be buying 4basebio stock or one of its competitors? The main competitors of 4basebio include Avacta Group (AVCT), Futura Medical (FUM), Faron Pharmaceuticals Oy (FARN), Scancell (SCLP), hVIVO (HVO), Poolbeg Pharma (POLB), Redx Pharma (REDX), Bioventix (BVXP), e-therapeutics (ETX), and Tissue Regenix Group (TRX). These companies are all part of the "biotechnology" industry.
Avacta Group (LON:AVCT) and 4basebio (LON:4BB) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, community ranking, earnings, institutional ownership, analyst recommendations, risk and profitability.
Avacta Group received 212 more outperform votes than 4basebio when rated by MarketBeat users.
9.1% of Avacta Group shares are owned by institutional investors. Comparatively, 9.0% of 4basebio shares are owned by institutional investors. 29.3% of Avacta Group shares are owned by company insiders. Comparatively, 62.2% of 4basebio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
4basebio has lower revenue, but higher earnings than Avacta Group. 4basebio is trading at a lower price-to-earnings ratio than Avacta Group, indicating that it is currently the more affordable of the two stocks.
4basebio has a net margin of 0.00% compared to 4basebio's net margin of -107.31%. Avacta Group's return on equity of -97.29% beat 4basebio's return on equity.
Avacta Group has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. Comparatively, 4basebio has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500.
In the previous week, 4basebio's average media sentiment score of 0.00 equaled Avacta Group'saverage media sentiment score.
Summary
Avacta Group beats 4basebio on 7 of the 12 factors compared between the two stocks.
Get 4basebio News Delivered to You Automatically
Sign up to receive the latest news and ratings for 4BB and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding 4BB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
4basebio Competitors List
Related Companies and Tools
